Endocrine & Hormone Testing Billing Services To Recover Every Dollar You've Earned

Most endocrinology practices and hormone testing labs lose 15-20% of collectible revenue annually; not from low testing volume, but evocative/suppression panel unit miscounting, thyroid reflex testing gaps, and dynamic testing administration billing errors that generalist billers miss entirely. TransLabs’ certified endocrine billing specialists close those gaps with a 98% clean claims rate and 30% faster A/R, with measurable growth in 90 days.
Endocrine and Hormone Testing Billing Services
0%
Client Retention Rate
0%
First-Pass Claim Rate
0%
Avg. Revenue Growth
0%
Avg. Denial Reduction

Why Endocrine and Hormone Testing Practices Lose Revenue Every Single Day

Endocrine billing carries a coding structure few specialties match: dynamic stimulation/suppression testing requiring timed blood draws, a drug administration component, and dedicated CPT codes billed per analyte per timepoint. Add reflex thyroid antibody rules, diabetes monitoring frequencies, and time-sensitive hormone draws, and generalists routinely misbill it. The loss compounds until an audit reveals it.

The Five Revenue Leaks Most Endocrine & Hormone Testing Practices Don't Know They Have

Evocative/Suppression Panel Unit Miscounting

Missing Drug Administration & Injection Billing on Stimulation Tests

Thyroid Reflex Testing Capture Gaps

Hormone Level Timing & Medical Necessity Denials

Endocrine and Hormone Testing Billing Services

Every Endocrine Testing Category, Billed Correctly; From Routine Panel to Dynamic Stimulation Test

From a routine TSH to a multi-hour ACTH stimulation test, our AAPC and AHIMA certified coders know the CPT coding rules, the panel unit logic, and the payer-specific medical necessity requirements for every category of endocrine and hormone testing.

Thyroid Function & Antibody Testing

CPT 84443, 84439, 84481, 86376, 86800, 86803

Thyroid-stimulating hormone (84443), free T4 (84439), free T3 (84481), thyroid peroxidase and thyroglobulin antibodies (86376, 86800), and thyroglobulin level (84432) used to diagnose and monitor hypothyroidism, hyperthyroidism, and autoimmune thyroid disease.

Key Billing Consideration

Reflex protocols that trigger free T4 or antibody testing off an abnormal TSH must be built into the ordering workflow --- missing that reflex step is one of the most common sources of uncollected revenue in routine thyroid management.

Evocative/Suppression Testing Panels

CPT 80400--80439

Dedicated multi-unit panel codes covering ACTH stimulation testing for adrenal insufficiency (80400), dexamethasone suppression panels (80420), growth hormone stimulation and suppression panels (80428, 80430), gonadotropin panels (80426), and the rapid combined anterior pituitary evaluation panel (80418).

Key Billing Consideration

Each of these codes represents a specific number of analyte measurements across defined timepoints, and the units billed must match the actual number of timed draws performed --- undercounting units on a multi-hour stimulation test is one of the most consistently underbilled services in endocrinology.

Dynamic Testing Drug Administration

Injection Billing

Administration of the stimulating or suppressing agent used in evocative testing, such as cosyntropin for an ACTH stimulation test or dexamethasone for a suppression test, billed separately from the laboratory panel code itself using the appropriate injection administration and drug codes.

Key Billing Consideration

The administration code and the drug itself are billed as distinct line items alongside the evocative testing panel code --- treating the injection as bundled into the lab panel is a routine source of underbilling on every dynamic testing encounter.

Adrenal & Pituitary Axis Testing

CPT 82533, 82024, 82088, 84244

Cortisol level testing (82533), adrenocorticotropic hormone (82024), aldosterone (82088), and renin activity (84244), used individually or as part of a broader diagnostic workup for adrenal insufficiency, Cushing syndrome, and primary aldosteronism.

Key Billing Consideration

Cortisol and ACTH follow a strong diurnal rhythm, and collection time relative to that rhythm should be documented --- a level drawn at the wrong time of day is both clinically less interpretable and more likely to be questioned on medical necessity review.

Reproductive & Gonadal Hormone Testing

CPT 83001, 83002, 82670, 84402--84403, 84146

Follicle-stimulating hormone (83001), luteinizing hormone (83002), estradiol (82670), free and total testosterone (84402, 84403), and prolactin (84146), used to evaluate infertility, hypogonadism, and pituitary dysfunction in both male and female patients.

Key Billing Consideration

These hormone levels are cycle-day or time-of-day dependent, and documenting the specimen collection context relative to that dependency is increasingly a medical necessity requirement, not just a clinical best practice.

Diabetes & Glucose Metabolism Testing

CPT 83036, 82947, 82951, 84681, 83525

Hemoglobin A1c (83036), fasting and random glucose (82947), glucose tolerance testing (82951), C-peptide (84681), and insulin level (83525), used to diagnose and monitor diabetes and evaluate insulin-secreting tumors.

Key Billing Consideration

Hemoglobin A1c testing is subject to payer-specific frequency limits, typically no more than four times per year for stable patients --- billing beyond that frequency without a documented treatment change is a routine, avoidable denial.

Calcium & Bone Metabolism Testing

CPT 83970, 82306, 82310, 82330

Parathyroid hormone (83970), vitamin D 25-hydroxy (82306), total and ionized calcium (82310, 82330), used to evaluate hyperparathyroidism, hypoparathyroidism, osteoporosis risk, and vitamin D deficiency.

Key Billing Consideration

Vitamin D testing carries some of the tightest frequency and medical necessity scrutiny in the endocrine test menu --- claims without a documented risk factor or symptomatic indication are among the most commonly denied in this category.

Neuroendocrine & Endocrine Tumor Marker Testing

CPT 82308, 83835, 84999

Calcitonin (82308) for medullary thyroid carcinoma surveillance, plasma or urine metanephrines (83835) for pheochromocytoma and paraganglioma workup, and other specialized endocrine tumor markers reported under unlisted chemistry codes when no specific CPT code exists.

Key Billing Consideration

Unlisted code claims require a detailed cover letter describing the exact test performed and its clinical necessity --- submitting an unlisted code without that documentation is one of the most reliable ways to guarantee a denial.

Our Laboratory RCM Services

TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.

Proficient Across Multiple LIS & EHRs to Simplify Your
Laboratory Management

ChartLogic
Collaborate md
Greenway health
Haemonetics
jane
cgm Labdaq
Modmed
open emr
Harris Data Integrity Solutions
siemens healthineers
Tebra
Oracle Health
Confience
Power path
Benchmark solutions
Xifin
Psyche Systems
veradigm
Turemed Lis
Telcor
Practice pro
novo path
Nextgen Healthcare
Next tech
meditech
Advanced data systems corporation
Logilab
Labware
Lab vantage
labs os
Epic
Dr Chrono
dendi
Corepoint
clinisys
Care Cloud
apex healthware
clinisys copathplus
Advanced md
softlab
athenaone

Serving Labs Across The United States

TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.

Medicare Compliance for Endocrine and Hormone Testing

Endocrine billing compliance centers on getting the details right on tests that don’t behave like routine single-draw labs: multi-unit stimulation panels, frequency-limited chronic disease monitoring, and hormone levels that are only medically meaningful when timing is documented. TransLabs builds each of these requirements directly into the billing workflow.
Evocative/Suppression Panel Unit Documentation

Each evocative or suppression testing panel code represents a specific, defined number of analyte measurements across timed intervals, and Medicare expects the units billed to exactly match the documented draws. TransLabs validates unit counts against the testing protocol documented in the chart before submission.

Local Coverage Determinations for Endocrine & Hormone Testing

Each Medicare Administrative Contractor maintains its own LCD specifying which ICD-10 diagnoses support coverage for thyroid, vitamin D, and specialized hormone testing. TransLabs maintains live LCD databases and validates diagnosis-to-test linkage on every Medicare claim before submission.

Frequency Limitations on Diabetes & Chronic Disease Monitoring

Medicare and most commercial payers limit hemoglobin A1c testing frequency for stable diabetic patients, typically to four times per year, unless a documented treatment change justifies more frequent testing. TransLabs monitors each patient's testing history against these limits before submission.

Vitamin D Testing Medical Necessity Documentation

Vitamin D testing faces some of the tightest medical necessity scrutiny in the endocrine test menu, with many payers requiring a documented risk factor, malabsorption condition, or specific symptomatic indication. TransLabs validates this documentation before claims are submitted.

Reflex Testing Documentation for Thyroid Panels

Reflex testing, such as free T4 or thyroid antibody panels triggered by an abnormal TSH, must be supported by documentation showing the reflex logic was followed and clinically appropriate. TransLabs builds these reflex rules directly into claim validation.

Unlisted Code Documentation for Specialized Endocrine Testing

Specialized endocrine and neuroendocrine tumor marker tests billed under unlisted chemistry codes require a detailed cover letter describing the test methodology and clinical necessity. TransLabs prepares this documentation as a standard part of unlisted code claim submission.

Clinical Laboratory Fee Schedule (CLFS) & PAMA Reporting

The CLFS sets Medicare payment rates for endocrine and hormone testing and updates annually on January 1, while laboratories meeting the applicable laboratory definition under PAMA carry mandatory private payer data reporting obligations. TransLabs monitors CLFS changes and tracks your PAMA obligations to ensure accurate, on-time compliance.

We Bill Only for Laboratories and That Difference Shows in Every Metric We Track

Most billing companies have never coded a multi-hour evocative testing panel and don’t know these codes represent multiple timed draws, not a single service. TransLabs was built for laboratory billing exclusively; our endocrine team understands both routine hormone panels and dynamic testing protocols; no divided attention, no generalist assumptions.

Endocrine & Hormone Testing-Exclusive Specialization

Endocrine testing is the focus with panel unit counting, reflex thyroid testing, and hormone timing, done right.

98% First-Pass Clean Claims Rate

98%+ clean claims rate across all lab clients with fewer denials, faster payments, stronger cash flow.

Dynamic Testing Panel Expertise

We know exactly what each evocative/suppression code represents and capture every administration and drug charge around it, every time.

High-Complexity Test Architecture

Purpose-built for endocrinology with reflex triggers, hormone timing, multi-timepoint panel units; not retrofitted from routine chemistry.

No Long-Term Contracts

Month-to-month, results-based partnership with measurable improvement in 90 days, no exit fees, just 30 days’ notice.

Transparent Reporting

Monthly dashboards with full visibility of clean claims rate, denial trends, A/R aging, and root cause analysis, no surprises.

Get Your Lab's Custom Revenue Recovery Plan

Schedule a call with our endocrine billing specialist. We’ll review your evocative testing unit accuracy, reflex thyroid capture, diabetes monitoring frequency compliance, and A/R days.

What Our Clients Say?

Linda Hutchinson
Linda Hutchinson
Laboratory Director
Our NGS panel denials dropped from 32% to under 6% within three months. TransLabs' expertise with molecular tier codes, prior authorization management, and LCD compliance has been invaluable. They understand the nuances of genetic testing billing that our previous vendor completely missed.
Peter Wozniak
Peter Wozniak
Pathologist & Laboratory Owner
We've worked with three other billing companies over the years. TransLabs is the only one that truly understands complex surgical pathology coding, immunohistochemistry billing, and the nuances of TC/PC modifiers. Clean claims rate improved to 99%, and our dermatopathology reimbursement increased 27%.
James Patton
James Patton
Cytogenetics Laboratory Manager
Before TransLabs, our FISH and karyotype claims were a constant struggle with denials and underpayments. Their coders actually understand probe configurations, complexity levels, and when to use 88271 versus 88275. Our cytogenetics revenue increased 34% in the first year.

Book Consultation Today!

Stop Leaving Reimbursements on the Table

Join 500+ practices and laboratories that trust TransLabs, the laboratory billing company built for growth. Start with our complimentary claims audit. Our endocrine billing specialists will review your evocative testing unit accuracy, your reflex thyroid capture, and your diabetes monitoring compliance to show you exactly what’s recoverable.

Dedicated billing specialist assigned to your practice or lab

Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers

Uncover your top 3 revenue leaks (panel undercounting, reflex gaps, frequency denials)

Custom strategy tailored to your test menu and EHR/LIS software

Live in 24 hours with no contracts and no upfront fees

Pay only a percentage of what we collect for you

Frequently Asked Questions

What is an evocative/suppression testing panel and how is it billed?

These are dedicated CPT codes (80400-80439) that represent a complete dynamic testing protocol, such as an ACTH stimulation test, built around multiple timed blood draws before and after a stimulating or suppressing agent is given. The units billed must match the actual number of timed measurements performed, not just one unit per encounter.
Yes. The administration of the stimulating or suppressing agent and the drug itself are billed as separate line items alongside the evocative testing panel code. Treating the injection as bundled into the lab panel code is a common source of underbilling.
Most payers limit A1c testing to four times per year for stable patients, though more frequent testing can be billed when supported by a documented treatment change or clinical instability. Billing beyond that frequency without that documentation is a routine denial trigger.
Typically 6-9% of net collections, reflecting the coding complexity specific to dynamic testing panels and reflex thyroid protocols. TransLabs charges transparently with no setup fees, tech fees, or long-term contracts. Revenue gains from accurate panel unit counting usually offset the fee within 30-60 days.
Yes. Our coders handle the full endocrine test menu, including thyroid function and antibody testing, evocative/suppression panels, adrenal and pituitary axis testing, reproductive hormone testing, diabetes monitoring, and specialized tumor marker testing.
Industry benchmark runs 10-14%, reflecting the medical necessity and panel complexity specific to this specialty. TransLabs clients typically operate below 5%. Common denial drivers include panel unit undercounting, missing reflex documentation, and frequency limit violations.
Yes, we’ve integrated with EHR and laboratory information systems commonly used in endocrinology practice settings, including automated reflex triggers, frequency tracking, and charge capture, typically completed within two weeks.
Most practices see results within 60-90 days: onboarding and credentialing in the first 30 days, panel unit and reflex-related denial improvement by day 60, and by day 90, a documented clean claims rate above 95% with measurable revenue growth in a performance report.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!